Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer

Immunotherapy has allowed major advances in oncology in the past years, in particular with the development of immune checkpoint inhibitors, but the clinical benefits are still limited, particularly in colorectal cancer (CRC). Our scientific approach is based on the search for innovative immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghione, Silvia, Racoeur, Cindy, Mabrouk, Nesrine, Shan, Jingxuan, Groetz, Emma, Ballot, Elise, Truntzer, Caroline, Chouchane, Lotfi, Végran, Frédérique, Paul, Catherine, Plenchette, Stéphanie, Bettaieb, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097540/
https://www.ncbi.nlm.nih.gov/pubmed/35572581
http://dx.doi.org/10.3389/fimmu.2022.875764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097540/
https://www.ncbi.nlm.nih.gov/pubmed/35572581
http://dx.doi.org/10.3389/fimmu.2022.875764

Ejemplares similares